Ultromics
PrivateLast Round
Corporate Funding
Dec 17, 2025
Est. Valuation
$300M
Total Funding Raised
$159M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Ultromics is a health tech company that provides an AI-powered cardiovascular diagnostic platform, EchoGo, to analyze echocardiograms for the early and more accurate detection of heart disease.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ultromics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Ultromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 17, 2025 | ||||
| Series C | Jul 31, 2025 | ||||
| Series C | Jul 31, 2024 | ||||
| Series B | Aug 16, 2021 | ||||
| Grant | Sep 8, 2020 | ||||
VC Round | Jun 18, 2020 |
Key People
Founding team and executive leadership
Ultromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCM Ventures | Series C |
| Nina Capital | VC Round |
| GV | Series B, Series C |
| Legal & General Group | Series C |
| Oxford Science Enterprises | VC Round, Series B, Series C, Series A, Seed |
| NHSX | Grant |
| Tanarra | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2026
Achieved Category III CPT reimbursement from the Centers for Medicare & Medicaid Services.
- Feb 23, 2026
Spun out from the University of Oxford.
Ultromics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ultromics's valuation, stock price, and market status.